Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group trial E2297
Jordan D. Berlin*, Paul Catalano, James P. Thomas, John W. Kugler, Daniel G. Haller, Al Bowen Benson
Dive into the research topics of 'Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group trial E2297'. Together they form a unique fingerprint.